In last trading session, Orchestra BioMed Holdings Inc (NASDAQ:OBIO) saw 85816.0 shares changing hands with its beta currently measuring 0.50. Company’s recent per share price level of $5.37 trading at -$0.25 or -4.45% at ring of the bell on the day assigns it a market valuation of $204.14M. That closing price of OBIO’s stock is at a discount of -87.34% from its 52-week high price of $10.06 and is indicating a premium of 26.26% from its 52-week low price of $3.96. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 91.91K if we extend that period to 3-months.
Orchestra BioMed Holdings Inc (NASDAQ:OBIO) trade information
Upright in the red during last session for losing -4.45%, in the last five days OBIO remained trading in the green while hitting it’s week-highest on Thursday, 01/02/25 when the stock touched $5.37 price level, adding 14.76% to its value on the day. Orchestra BioMed Holdings Inc’s shares saw a change of 34.25% in year-to-date performance and have moved 34.25% in past 5-day. Orchestra BioMed Holdings Inc (NASDAQ:OBIO) showed a performance of 6.76% in past 30-days. Number of shares sold short was 0.7 million shares which calculate 12.57 days to cover the short interests.
Orchestra BioMed Holdings Inc (OBIO) estimates and forecasts
Statistics highlight that Orchestra BioMed Holdings Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -31.24% of value to its shares in past 6 months, showing an annual growth rate of -12.16% while that of industry is 17.00. Apart from that, the company came lowering its revenue forecast for fiscal year 2025.
Orchestra BioMed Holdings Inc (NASDAQ:OBIO)’s Major holders
Insiders are in possession of 22.00% of company’s total shares while institution are holding 54.96 percent of that, with stock having share float percentage of 70.47%. Investors also watch the number of corporate investors in a company very closely, which is 54.96% institutions for Orchestra BioMed Holdings Inc that are currently holding shares of the company.
